Naesens Janwillem 4
4 · Cyteir Therapeutics, Inc. · Filed Feb 24, 2022
Insider Transaction Report
Form 4
Naesens Janwillem
10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2022-02-22+14,150→ 14,150 totalExercise: $5.96Exp: 2032-02-22→ Common Stock (14,150 underlying)
Footnotes (1)
- [F1]The shares of common stock underlying this stock option award vest in full on February 22, 2023, subject to the Reporting Person's continued service to the board of directors of the Company through the applicable vesting date.